These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

910 related items for PubMed ID: 8181146

  • 1. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T.
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [Abstract] [Full Text] [Related]

  • 2. Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress.
    Yamazaki T, Yazaki Y.
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S43-7; discussion S49-50. PubMed ID: 10076920
    [Abstract] [Full Text] [Related]

  • 3. Role of the renin-angiotensin system in cardiac hypertrophy.
    Yamazaki T, Komuro I, Yazaki Y.
    Am J Cardiol; 1999 Jun 17; 83(12A):53H-57H. PubMed ID: 10750588
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
    Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y.
    J Hypertens Suppl; 1994 Nov 17; 12(9):S23-7. PubMed ID: 7884580
    [Abstract] [Full Text] [Related]

  • 5. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K, Niimura S, Katoh K, Fukuchi S.
    Life Sci; 1994 Nov 17; 54(25):1987-94. PubMed ID: 8201847
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y, Nakamura T, Takano H, Kimura H, Obata JE, Takeda S, Hata A, Shido K, Mochizuki S, Yoshida Y.
    J Lab Clin Med; 2000 Apr 17; 135(4):353-9. PubMed ID: 10779052
    [Abstract] [Full Text] [Related]

  • 7. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug 17; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 8. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG, Scheer C, Rupp H.
    J Hypertens Suppl; 1997 Dec 17; 15(6):S13-9. PubMed ID: 9493122
    [Abstract] [Full Text] [Related]

  • 9. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M.
    Blood Press Suppl; 1994 Dec 17; 5():94-8. PubMed ID: 7889211
    [Abstract] [Full Text] [Related]

  • 10. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
    Mori T, Nishimura H, Ueyama M, Kubota J, Kawamura K.
    Jpn Circ J; 1995 Sep 17; 59(9):624-30. PubMed ID: 7500546
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of three sites of renin-angiotensin blockade on the regression of left ventricular hypertrophy in spontaneously hypertensive rats.
    Zhang Q, Kohara K, Qui HY, Hiwada K.
    Am J Ther; 1997 Sep 17; 4(5-6):199-202. PubMed ID: 10423611
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T, Masuda J, Sutani T, Sakaguchi Y, Tsuchihashi M, Tsuruta S, Iwano M, Dohi K, Nakamura Y, Konishi N.
    Blood Press Suppl; 1994 Sep 17; 5():89-93. PubMed ID: 7889210
    [Abstract] [Full Text] [Related]

  • 13. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
    Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y.
    J Hypertens Suppl; 1994 Dec 17; 12(10):S153-7. PubMed ID: 7769485
    [Abstract] [Full Text] [Related]

  • 14. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
    Hara K, Kobayashi N, Nakano S, Mori Y, Tsubokou Y, Matsuoka H.
    Hypertens Res; 2001 Jan 17; 24(1):55-64. PubMed ID: 11213031
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA.
    Hypertension; 2000 Jan 17; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [Abstract] [Full Text] [Related]

  • 16. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov 17; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 17. Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
    Kohya T, Yokoshiki H, Tohse N, Kanno M, Nakaya H, Saito H, Kitabatake A.
    Circ Res; 1995 May 17; 76(5):892-9. PubMed ID: 7729007
    [Abstract] [Full Text] [Related]

  • 18. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
    Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T.
    J Hypertens; 1993 Dec 17; 11(12):1347-55. PubMed ID: 8133017
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Ishimura Y, Chatani F, Iwao H.
    J Pharmacol Exp Ther; 1995 Apr 17; 273(1):509-15. PubMed ID: 7714806
    [Abstract] [Full Text] [Related]

  • 20. TCV-116 stimulates eNOS and caveolin-1 expression and improves coronary microvascular remodeling in normotensive and angiotensin II-induced hypertensive rats.
    Kobayashi N, Mori Y, Nakano S, Tsubokou Y, Kobayashi T, Shirataki H, Matsuoka H.
    Atherosclerosis; 2001 Oct 17; 158(2):359-68. PubMed ID: 11583714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.